ARTICLE | Clinical News
Viramidine: Phase III started
June 21, 2004 7:00 AM UTC
VRX started VISER2, the second of two international Phase III trials comparing its Viramidine plus pegylated interferon to ribavirin plus pegylated interferon in about 1,000 patients. VRX hopes to com...